BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 37644215)

  • 1. Multiomics and blood-based biomarkers of electroconvulsive therapy in severe and treatment-resistant depression: study protocol of the DetECT study.
    von Mücke-Heim IA; Pape JC; Grandi NC; Erhardt A; Deussing JM; Binder EB
    Eur Arch Psychiatry Clin Neurosci; 2024 Apr; 274(3):673-684. PubMed ID: 37644215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST): study protocol for a randomized non-inferiority trial of magnetic seizure therapy versus electroconvulsive therapy.
    Daskalakis ZJ; Tamminga C; Throop A; Palmer L; Dimitrova J; Farzan F; Thorpe KE; McClintock SM; Blumberger DM
    Trials; 2021 Nov; 22(1):786. PubMed ID: 34749782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonconvulsive Electrotherapy for Treatment Resistant Unipolar and Bipolar Major Depressive Disorder: A Proof-of-concept Trial.
    Regenold WT; Noorani RJ; Piez D; Patel P
    Brain Stimul; 2015; 8(5):855-61. PubMed ID: 26187603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT.
    Allen AP; Naughton M; Dowling J; Walsh A; Ismail F; Shorten G; Scott L; McLoughlin DM; Cryan JF; Dinan TG; Clarke G
    J Affect Disord; 2015 Nov; 186():306-11. PubMed ID: 26275358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant Effects of Electroconvulsive Therapy Unrelated to the Brain's Functional Network Connectivity alterations at an Individual Level.
    Chen GD; Ji F; Li GY; Lyu BX; Hu W; Zhuo CJ
    Chin Med J (Engl); 2017 Feb; 130(4):414-419. PubMed ID: 28218214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The priming effect of repetitive transcranial magnetic stimulation on clinical response to electroconvulsive therapy in treatment-resistant depression: a randomized, double-blind, sham-controlled study.
    Rothärmel M; Quesada P; Husson T; Harika-Germaneau G; Nathou C; Guehl J; Dalmont M; Opolczynski G; Miréa-Grivel I; Millet B; Gérardin E; Compère V; Dollfus S; Jaafari N; Bénichou J; Thill C; Guillin O; Moulier V
    Psychol Med; 2023 Apr; 53(5):2060-2071. PubMed ID: 34579796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of treatment resistance on outcome and course of electroconvulsive therapy in major depressive disorder.
    Rovers JJE; Vissers P; Loef D; van Waarde JA; Verdijk JPAJ; Broekman BFP; Vergouwen ACM; Oudega ML; van Exel E; Coenen R; Everaerd DS; Tendolkar I; Dols A; van Eijndhoven PFP
    Acta Psychiatr Scand; 2023 Jun; 147(6):570-580. PubMed ID: 37020420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ELEctroconvulsive therapy (ECT) vs. Ketamine in patients with Treatment-resistant Depression: The ELEKT-D study protocol.
    Mathew SJ; Wilkinson ST; Altinay M; Asghar-Ali A; Chang LC; Collins KA; Dale RM; Hu B; Krishnan K; Kellner CH; Malone DA; Murrough JW; Ostroff RB; Sanacora G; Shao M; Anand A
    Contemp Clin Trials; 2019 Feb; 77():19-26. PubMed ID: 30572160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation and Improvement of Depression Following Electroconvulsive Therapy in Treatment-Resistant Depression.
    Kruse JL; Congdon E; Olmstead R; Njau S; Breen EC; Narr KL; Espinoza R; Irwin MR
    J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29489077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term quality of life in treatment-resistant depression after electroconvulsive therapy.
    Lex H; Nevers SW; Jensen EL; Ginsburg Y; Maixner DF; Mickey BJ
    J Affect Disord; 2021 Aug; 291():135-139. PubMed ID: 34038830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Electroconvulsive Therapy in Adolescents With Treatment-Resistant Depressive Disorders: A Case Series.
    Zhand N; Courtney DB; Flament MF
    J ECT; 2015 Dec; 31(4):238-45. PubMed ID: 25830809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol.
    Phillips JL; Jaworska N; Kamler E; Bhat V; Blier J; Foster JA; Hassel S; Ho K; McMurray L; Milev R; Moazamigoudarzi Z; Placenza FM; Richard-Devantoy S; Rotzinger S; Turecki G; Vazquez GH; Kennedy SH; Blier P;
    BMC Psychiatry; 2020 Jun; 20(1):268. PubMed ID: 32487236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Episodic memory following deep brain stimulation of the ventral anterior limb of the internal capsule and electroconvulsive therapy.
    Bergfeld IO; Mantione M; Hoogendoorn MLC; Horst F; Notten P; Schuurman PR; Denys D
    Brain Stimul; 2017; 10(5):959-966. PubMed ID: 28754306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mood and neuropsychological effects of different doses of ketamine in electroconvulsive therapy for treatment-resistant depression.
    Zhong X; He H; Zhang C; Wang Z; Jiang M; Li Q; Zhang M; Huang X
    J Affect Disord; 2016 Sep; 201():124-30. PubMed ID: 27208499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroconvulsive therapy improves clinical manifestations of treatment-resistant depression without changing serum BDNF levels.
    Rapinesi C; Kotzalidis GD; Curto M; Serata D; Ferri VR; Scatena P; Carbonetti P; Napoletano F; Miele J; Scaccianoce S; Del Casale A; Nicoletti F; Angeletti G; Girardi P
    Psychiatry Res; 2015 Jun; 227(2-3):171-8. PubMed ID: 25910420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depressive Symptom Dimensions in Treatment-Resistant Major Depression and Their Modulation With Electroconvulsive Therapy.
    Wade BSC; Hellemann G; Espinoza RT; Woods RP; Joshi SH; Redlich R; Jørgensen A; Abbott CC; Oedegaard KJ; McClintock SM; Oltedal L; Narr KL
    J ECT; 2020 Jun; 36(2):123-129. PubMed ID: 31464814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring cortical predictors of clinical response to electroconvulsive therapy in major depression.
    Schmitgen MM; Kubera KM; Depping MS; Nolte HM; Hirjak D; Hofer S; Hasenkamp JH; Seidl U; Stieltjes B; Maier-Hein KH; Sambataro F; Sartorius A; Thomann PA; Wolf RC
    Eur Arch Psychiatry Clin Neurosci; 2020 Mar; 270(2):253-261. PubMed ID: 31278421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of electroconvulsive therapy on cerebral monoamine oxidase A expression in treatment-resistant depression investigated using positron emission tomography.
    Baldinger-Melich P; Gryglewski G; Philippe C; James GM; Vraka C; Silberbauer L; Balber T; Vanicek T; Pichler V; Unterholzner J; Kranz GS; Hahn A; Winkler D; Mitterhauser M; Wadsak W; Hacker M; Kasper S; Frey R; Lanzenberger R
    Brain Stimul; 2019; 12(3):714-723. PubMed ID: 30635228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case report: delayed response after electroconvulsive therapy in a patient with major depressive disorder.
    Chen F; Sidhom E; Yang S; Ruiz-Mendoza E; Essem J
    BMC Psychiatry; 2021 Jan; 21(1):50. PubMed ID: 33478427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early improvement as a predictor of final remission in patients with treatment-resistant depression receiving electroconvulsive therapy with ketofol anesthesia.
    Zheng W; He M; Gu LM; Lao GH; Wang DF; Mai JX; Wu HW; Nie S; Huang X
    J Affect Disord; 2022 Aug; 310():223-227. PubMed ID: 35550826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.